ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Mercaptor Announces Epilepsy Preclinical Program americanpharmaceuticalreview
January 13, 2020Mercaptor Discoveries announced the advancement of its preclinical program in epilepsy. The program culminates in human trials, beginning in early 2022. Their primary candidate has demonstrated reproducible POC and efficacy in animal seizure models.
Pharma Sources Insight July 2025
